Monspas MF 80mg/250mg Tablet
Marketer
Veemon Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Monspas MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Meftal Spas 80mg/250mg Tablet. This formulation alleviates abdominal pain, distension, discomfort, and spasms by relaxing the gastrointestinal tract's musculature. It also inhibits pain-inducing neurotransmitters. Meftal Spas 80mg/250mg Tablets should be taken with meals, following your doctor's prescribed dosage and regimen. Your individual dosage depends on your condition and treatment response. Continue the medication as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your physician of all other medications you're using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, anorexia, thirst, and heartburn; most are transient and self-limiting. Report any concerning side effects immediately. Dizziness and drowsiness are potential effects; avoid driving or mentally demanding tasks until the medication's impact is known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Prior to commencing treatment, disclose any pregnancy, pregnancy plans, or breastfeeding. Kidney or liver disease should also be reported for appropriate dosage adjustment.
Primary Ingredients of Monspas MF 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Monspas MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Monspas MF 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 80mg/250mg Monspas MF tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Monspas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Monspas MF 80mg/250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Monspas MF 80mg/250mg tablets with a meal.
How Monspas MF 80mg/250mg Tablet works:
Each Monspas MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory chemicals responsible for pain and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Monspas MF 80mg/250mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Monspas MF 80mg/250mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Monspas MF 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Monspas MF 80mg/250mg Tablets, a potential side effect of the medication, including vertigo.
KidneyCAUTION
Patients with kidney impairment should use Monspas MF 80mg/250mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Monspas MF 80mg/250mg tablets; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Monspas MF 80mg/250mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Monspas MF 80mg/250mg Tablet :
Should you forget to take a Monspas MF 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Monspas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently